DYNAMICS OF SIgA CONTENT IN BREAST MILK WHEN RISK FACTORS AND LACTATIONAL CHARACTERISTICS ARE CONSIDERED
The leading role associated with an anti-infective action of breast milk belongs to secretory IgA (SIgA). Therefore, the determination of the level of SIgA in colostrum and milk of mothers with different lactation levels and mothers at risk at different levels and duration of lactation has a practical interest.
Aim. The research aims at studying the dynamics of SIgA content in breast milk, taking into account risk factors and features of lactation.
Material and Methods. The content of SIgA in colostrum and breast milk of 372 mothers with full lactation and 208 with hypogalactia, of which 72 with early and 146 with late hypogalactia at different times of lactation (1-8 days and 1-3 months) was determined. The SIgA content was also studied in mothers; 65 with preeclampsia, including 12 with early hypogalactia, 24 with late hypogalactia, 23 with full lactation, and 44 with anemia of pregnancy, including 12 with early hypogalactia, 19 with late hypogalactia and 13 with full lactation. The determination of SIgA content in colostrum and milk was performed using the method of simple radial immunodiffusion in a gel by G. Mancini et al.
Results and Discussion. The SIgA concentration in colostrum and breast milk decreased during the secretion process. In early hypogalactia, the content of SIgA did not differ significantly from the level of SIgA in colostrum and breast milk with full lactation in the early neonatal period and at 1-3 months of secretion. In the late hypogalactia, SIgA content did not differ significantly from its level in the control group. Due to the lower amount of milk received by the mother's child with hypogalactia, the supply of children with SIgA is insufficient, and the deficit is higher the sooner the hypogalactia develops. Similar changes in the dynamics of SIgA content have been found in mothers with preeclampsia and at different levels of lactation. The exception was the content of SIgA in colostrum and milk of mothers with anemia of pregnancy and early hypogalactia, which in the first five days of lactation was lower than in mothers with full lactation.
Conclusion. The SIgA concentration in colostrum and breast milk decreases during the secretion process. The level of lactation does not affect the dynamics of SIgA content, except for the SIgA content in colostrum and breast milk of mothers with anemia of pregnancy and hypogalactia in the early stages of secretion. Despite the absence of a significant difference in SIgA levels in mothers with different levels of lactation due to less colostrum and milk received by children with early and late hypogalactia, the supply of SIgA is insufficient, and the cumulative deficit is higher the faster the hypogalactia develops.
Agarwal S, Karmaus W, Davis S, et al. Immune markers in breast milk and fetal and maternal body fluids: A systematic review of perinatal concentrations. J Hum Lact 2011;27:171-186. doi: 10.1177/0890334410395761.
Frost BL, Jilling T, Lapin B, et al. Maternal breast milk transforming growth factor-beta and feeding intolerance in preterm infants. Pediatr Res 2014;76:386-393. doi: 10.1038/pr.2014.96.
Nolan LS, Parks OB, Good MA. Review of the immunomodulating components of maternal breast milk and protection against necrotizing enterocolitis. Nutrients 2019 Dec 19;12(1):14. doi: 10.3390/nu12010014. PMID: 31861718; PMCID: PMC7019368.
Jorvinen KM, Martin H, Oyoshi MK. Immunomodulatory effects of breast milk on food allergy. Ann Allergy Asthma Immunol 2019 Aug;123(2):133-143. doi: 10.1016/j.anai.2019.04.022. Epub 2019 Apr 29. PMID: 31048004; PMCID: PMC6693634.
Gopalakrishna KP, Hand TW. Influence of maternal milk on the neonatal intestinal microbiome. Nutrients 2020 Mar 20;12(3):823. doi: 10.3390/nu12030823. PMID: 32244880; PMCID: PMC7146310.
Baird JK, Jensen SM, Urba WJ, et al. SARS-CoV-2 Antibodies detected in mother's milk post-vaccination. J Hum Lact. 2021 Aug;37(3):492-498. doi: 10.1177/08903344211030168. Epub 2021 Jul 23. PMID: 34297643; PMCID: PMC8685565
Kumar S, Rasalam JE, David VT, et al. Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers. Vox Sang 2022 Jun;117(6):847-852. doi: 10.1111/vox.13253. Epub 2022 Jan 26. PMID: 35080045.
Rio-Aige K, Azagra-Boronat I, Castell M, et al. The breast milk immunoglobulinome. Nutrients 2021 May 26;13(6):1810. doi: 10.3390/nu13061810. PMID: 34073540; PMCID: PMC8230140.
Islam SN, Ahmed L, Khan MNI, et al. Immune components (IgA, IgM, IgG, immune cells) of colostrum of Bangladeshi mothers. Pediatr Int 2006;48:543-548. doi: 10.1111/j.1442-200X.2006.02291.x.
Bachour P, Yafawi R, Jaber F, et al. Effects of smoking, mother's age, body mass index, and parity number on lipid, protein, and secretory immunoglobulin concentrations of human milk. Breastfeed Med 2012;7:179-188. doi: 10.1089/bfm.2011.0038.
Demers-Mathieu V, Huston RK, Markell AM, et al. Differences in maternal immunoglobulins within mother's own breast milk and donor breast milk and across digestion in preterm infants. Nutrients 2019;11:920. doi: 10.3390/nu11040920.
Palmeira P, Carneiro-Sampaio M. Immunology of breast milk. Rev Assoc Med Bras 2016 Sep;62(6):584-593. doi: 10.1590/1806-9282.62.06.584. PMID: 27849237.
Fujita M, Wander K, Paredes Ruvalcaba N, et al Human milk SIgA antibody in relation to maternal nutrition and infant vulnerability in northern Kenya. Evol Med Public Health 2019 Nov 11;2019(1):201-211. doi: 10.1093/emph/eoz030. PMID: 32405414; PMCID: PMC7216193.
Tkachenko SK, Dobrianskii DA, Ioffe VS. Antenatal'nye faktory riska i sostoianie mestnoi immunologicheskoi zashchity kishechnika u nedonoshennykh novorozhdennykh [Prenatal risk factors and the status of local defense of the intestines in premature newborn infants]. Pediatriia 1992;(1):14-8. Russian. PMID: 1614796.
Franoa EL, Silva VA, Volpato RM, et al. Maternal anemia induces changes in immunological and nutritional components of breast milk. J Matern Fetal Neonatal Med 2013 Aug; 26(12):1223-7.
This work is licensed under a Creative Commons Attribution 4.0 International License.